These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2459894)

  • 1. Hemiballismus: changes in cerebrospinal fluid.
    Kostic V; Djuricic B; Paschen W
    Acta Neurol Scand; 1988 Aug; 78(2):115-7. PubMed ID: 2459894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
    Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
    Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of drug-induced changes in dopamine and serotonin metabolite concentrations in the CSF of the rat.
    Mignot E; Laude D; Elghozi JL
    J Neurochem; 1984 Mar; 42(3):819-25. PubMed ID: 6198472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine metabolites in the CSF of conscious unrestrained cats.
    Degrell I; Zenner K; Kummer P; Stock G
    Brain Res; 1983 Oct; 277(2):283-7. PubMed ID: 6196083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraventricular microdialysis: a new method for determining monoamine metabolite concentrations in the cerebrospinal fluid of freely moving rats.
    Becker JB; Adams F; Robinson TE
    J Neurosci Methods; 1988 Jul; 24(3):259-69. PubMed ID: 2458511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmortem changes in the levels of monoamine metabolites in human cerebrospinal fluid.
    Endo T; Hara S; Kuriiwa F; Kano S
    Forensic Sci Int; 1990 Jan; 44(1):61-8. PubMed ID: 1689267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF HVA and 5-HIAA.
    Wood JH
    Neurology; 1979 Jun; 29(6):910-12. PubMed ID: 572023
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of rat ovariectomy on CSF monoamine metabolite levels and elimination.
    Duval C; Mignot E
    J Neurochem; 1985 Apr; 44(4):1312-4. PubMed ID: 2579209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders.
    Tabaddor K; Wolfson LI; Sharpless NS
    Neurology; 1978 Dec; 28(12):1249-53. PubMed ID: 569783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Homovanillic (HVA) and 5-hydroxyindoleacetic (5-HIAA) acid concentration in the cerebrospinal fluid of patients with supratentorial tumors and symptoms of intracranial hypertension (preliminary report)].
    Majchrzak H; Kmieciak-KoĊ‚ada K; Herman Z; Wencel T
    Neurol Neurochir Pol; 1980; 14(1):87-90. PubMed ID: 6154903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF monamine metabolites in movement disorders and normal aging.
    Stahl SM; Faull KF; Barchas JD; Berger PA
    Arch Neurol; 1985 Feb; 42(2):166-9. PubMed ID: 2579626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid.
    Cohen DJ; Shaywitz BA; Johnson WT; Bowers M
    Arch Gen Psychiatry; 1974 Dec; 31(6):845-53. PubMed ID: 4441252
    [No Abstract]   [Full Text] [Related]  

  • 13. Concentrations of homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid from human infants in the perinatal period.
    Silverstein FS; Donn S; Buchanan K; Johnston MV
    J Neurochem; 1984 Dec; 43(6):1769-72. PubMed ID: 6208340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
    Soininen H; MacDonald E; Rekonen M; Riekkinen PJ
    Acta Neurol Scand; 1981 Aug; 64(2):101-7. PubMed ID: 6172950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cerebrospinal fluid levels of dopamine metabolites by gas chromatography.
    Watson E; Wilk S
    Psychopharmacologia; 1975 Apr; 42(1):57-6. PubMed ID: 1153623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Central metabolism of dopamine and serotonin. IV. Preliminary determinations of cerebrospinal fluid HVA and 5-HIAA in epileptic syndromes].
    Mandarini A; Buscaino GA; Rossi V; Orefice G; Carrieri P; Campanella G
    Acta Neurol (Napoli); 1976; 31(5):628-31. PubMed ID: 1015386
    [No Abstract]   [Full Text] [Related]  

  • 17. Reye syndrome: monoamine metabolites in ventricular fluid.
    Shaywitz BA; Venes J; Cohen DJ; Bowers MB
    Neurology; 1979 Apr; 29(4):467-72. PubMed ID: 571546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)].
    Carrieri P; Campanella G; Mandarini A; Orefice G; Buscaino GA
    Acta Neurol (Napoli); 1976; 31(5):558-64. PubMed ID: 1015382
    [No Abstract]   [Full Text] [Related]  

  • 19. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method.
    Mena MA; Aguado EG; de Yebenes JG
    Acta Neurol Scand; 1984 Apr; 69(4):218-25. PubMed ID: 6204498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.